Overview Dividends

(IVZ) Invesco - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: BMG491BT1088

ETF, Mutual Fund, Portfolio Management, Separate Account

IVZ EPS (Earnings per Share)

EPS (Earnings per Share) of IVZ over the last years for every Quarter: "2020-09": 0.53, "2020-12": 0.72, "2021-03": 0.68, "2021-06": 0.78, "2021-09": 0.77, "2021-12": 0.86, "2022-03": 0.56, "2022-06": 0.39, "2022-09": 0.34, "2022-12": 0.39, "2023-03": 0.38, "2023-06": 0.31, "2023-09": 0.35, "2023-12": 0.47, "2024-03": 0.33, "2024-06": 0.43, "2024-09": 0.44, "2024-12": 0.52, "2025-03": 0.44, "2025-06": 0.36, "2025-09": 0.61,
EPS Growth (3Y CAGR): 17.66%
EPS Trend (3Y Correlation): 57.6%

IVZ Revenue

Revenue of IVZ over the last years for every Quarter: 2020-09: 1497.6, 2020-12: 1630.1, 2021-03: 1659.7, 2021-06: 1721.4, 2021-09: 1750, 2021-12: 1763.4, 2022-03: 1629.4, 2022-06: 1530.4, 2022-09: 1445.7, 2022-12: 1443.4, 2023-03: 1418.2, 2023-06: 1442.8, 2023-09: 1442, 2023-12: 1413.4, 2024-03: 1475.3, 2024-06: 1483.3, 2024-09: 1515.4, 2024-12: 1593, 2025-03: 1529.2, 2025-06: 1515.5, 2025-09: 2980.3,
Revenue Growth (3Y CAGR): 30.17%
Revenue Trend (3Y Correlation): 59.5%

Description: IVZ Invesco November 03, 2025

Invesco Ltd. (NYSE: IVZ) is a global investment manager that serves a broad client base-including retail, institutional, high-net-worth, public entities, and sovereign wealth funds-through a suite of equity, fixed-income, multi-asset, commodity, and alternative strategies delivered via mutual funds, ETFs, and private funds.

As of the most recent filing, Invesco reported $1.6 trillion in assets under management (AUM), with a 4.2 % year-over-year growth driven largely by inflows into its active equity and ESG-focused products. The firm’s revenue mix remains heavily weighted toward fee income (≈ 85 % of total revenue), making it sensitive to fee compression trends and the ongoing shift toward low-cost passive investing. Key sector drivers include rising demand for quantitative and factor-based strategies, as well as regulatory scrutiny on fee disclosures that could affect profitability.

For a deeper quantitative view of Invesco’s valuation and risk profile, you might explore the ValueRay platform.

IVZ Stock Overview

Market Cap in USD 10,549m
Sub-Industry Asset Management & Custody Banks
IPO / Inception 1995-08-24

IVZ Stock Ratings

Growth Rating 49.8%
Fundamental 74.7%
Dividend Rating 60.0%
Return 12m vs S&P 500 15.2%
Analyst Rating 3.07 of 5

IVZ Dividends

Dividend Yield 12m 3.55%
Yield on Cost 5y 6.90%
Annual Growth 5y 1.27%
Payout Consistency 93.3%
Payout Ratio 43.3%

IVZ Growth Ratios

Growth Correlation 3m 89%
Growth Correlation 12m 46.6%
Growth Correlation 5y -19.4%
CAGR 5y 19.06%
CAGR/Max DD 3y (Calmar Ratio) 0.52
CAGR/Mean DD 3y (Pain Ratio) 1.39
Sharpe Ratio 12m 0.78
Alpha 7.55
Beta 1.629
Volatility 32.30%
Current Volume 3953.6k
Average Volume 20d 4174.6k
Stop Loss 22.6 (-3.3%)
Signal 0.58

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (998.9m TTM) > 0 and > 6% of Revenue (6% = 457.1m TTM)
FCFTA 0.05 (>2.0%) and ΔFCFTA -0.45pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 1.87% (prev 20.51%; Δ -18.64pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.05 (>3.0%) and CFO 1.39b > Net Income 998.9m (YES >=105%, WARN >=100%)
Net Debt (-973.1m) to EBITDA (1.37b) ratio: -0.71 <= 3.0 (WARN <= 3.5)
Current Ratio 1.17 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (454.6m) change vs 12m ago -0.22% (target <= -2.0% for YES)
Gross Margin 42.97% (prev 32.44%; Δ 10.53pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 27.24% (prev 21.41%; Δ 5.83pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 17.23 (EBITDA TTM 1.37b / Interest Expense TTM 71.9m) >= 6 (WARN >= 3)

Altman Z'' 1.60

(A) 0.01 = (Total Current Assets 973.1m - Total Current Liabilities 830.4m) / Total Assets 28.44b
(B) 0.25 = Retained Earnings (Balance) 6.99b / Total Assets 28.44b
(C) 0.04 = EBIT TTM 1.24b / Avg Total Assets 27.97b
(D) 0.44 = Book Value of Equity 6.07b / Total Liabilities 13.65b
Total Rating: 1.60 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 74.71

1. Piotroski 6.50pt = 1.50
2. FCF Yield 8.14% = 4.07
3. FCF Margin 18.29% = 4.57
4. Debt/Equity 0.54 = 2.36
5. Debt/Ebitda -0.71 = 2.50
6. ROIC - WACC (= 1.43)% = 1.78
7. RoE 6.99% = 0.58
8. Rev. Trend 59.48% = 4.46
9. EPS Trend 57.59% = 2.88

What is the price of IVZ shares?

As of November 06, 2025, the stock is trading at USD 23.37 with a total of 3,953,575 shares traded.
Over the past week, the price has changed by -3.03%, over one month by -3.15%, over three months by +11.48% and over the past year by +37.04%.

Is Invesco a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Invesco (NYSE:IVZ) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 74.71 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IVZ is around 22.09 USD . This means that IVZ is currently overvalued and has a potential downside of -5.48%.

Is IVZ a buy, sell or hold?

Invesco has received a consensus analysts rating of 3.07. Therefor, it is recommend to hold IVZ.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 11
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the IVZ price?

Issuer Target Up/Down from current
Wallstreet Target Price 26.3 12.4%
Analysts Target Price 26.3 12.4%
ValueRay Target Price 24.3 4.1%

IVZ Fundamental Data Overview November 02, 2025

Market Cap USD = 10.55b (10.55b USD * 1.0 USD.USD)
P/E Trailing = 16.1225
P/E Forward = 10.4493
P/S = 1.6803
P/B = 0.9693
P/EG = 0.5047
Beta = 1.629
Revenue TTM = 7.62b USD
EBIT TTM = 1.24b USD
EBITDA TTM = 1.37b USD
Long Term Debt = 7.09b USD (from longTermDebt, last fiscal year)
Short Term Debt = 66.2m USD (from shortTermDebt, last fiscal year)
Debt = 7.55b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -973.1m USD (from netDebt column, last quarter)
Enterprise Value = 17.12b USD (10.55b + Debt 7.55b - CCE 973.1m)
Interest Coverage Ratio = 17.23 (Ebit TTM 1.24b / Interest Expense TTM 71.9m)
FCF Yield = 8.14% (FCF TTM 1.39b / Enterprise Value 17.12b)
FCF Margin = 18.29% (FCF TTM 1.39b / Revenue TTM 7.62b)
Net Margin = 13.11% (Net Income TTM 998.9m / Revenue TTM 7.62b)
Gross Margin = 42.97% ((Revenue TTM 7.62b - Cost of Revenue TTM 4.34b) / Revenue TTM)
Gross Margin QoQ = 54.05% (prev 33.28%)
Tobins Q-Ratio = 0.60 (Enterprise Value 17.12b / Total Assets 28.44b)
Interest Expense / Debt = 0.34% (Interest Expense 25.7m / Debt 7.55b)
Taxrate = 3.06% (9.70m / 317.1m)
NOPAT = 1.20b (EBIT 1.24b * (1 - 3.06%))
Current Ratio = 1.17 (Total Current Assets 973.1m / Total Current Liabilities 830.4m)
Debt / Equity = 0.54 (Debt 7.55b / totalStockholderEquity, last quarter 14.01b)
Debt / EBITDA = -0.71 (Net Debt -973.1m / EBITDA 1.37b)
Debt / FCF = -0.70 (Net Debt -973.1m / FCF TTM 1.39b)
Total Stockholder Equity = 14.28b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.51% (Net Income 998.9m / Total Assets 28.44b)
RoE = 6.99% (Net Income TTM 998.9m / Total Stockholder Equity 14.28b)
RoCE = 5.80% (EBIT 1.24b / Capital Employed (Equity 14.28b + L.T.Debt 7.09b))
RoIC = 8.57% (NOPAT 1.20b / Invested Capital 14.01b)
WACC = 7.14% (E(10.55b)/V(18.10b) * Re(12.02%) + D(7.55b)/V(18.10b) * Rd(0.34%) * (1-Tc(0.03)))
Discount Rate = 12.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.22%
[DCF Debug] Terminal Value 69.60% ; FCFE base≈1.42b ; Y1≈1.76b ; Y5≈3.00b
Fair Price DCF = 62.65 (DCF Value 27.89b / Shares Outstanding 445.1m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 57.59 | EPS CAGR: 17.66% | SUE: 3.09 | # QB: 1
Revenue Correlation: 59.48 | Revenue CAGR: 30.17% | SUE: 3.45 | # QB: 1

Additional Sources for IVZ Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle